The global NGS-Based Monitoring And Diagnostic Test market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform. The report further highlights the market drivers, restraints and the top manufacturers at the global and regional levels. For a thorough understanding, the report also offers market segmentation and regional analysis for the forecast period from 2020 to 2025.
According to this study, over the next five years the NGS-Based Monitoring And Diagnostic Test market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in NGS-Based Monitoring and Diagnostic Test business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of NGS-Based Monitoring and Diagnostic Test market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the NGS-Based Monitoring and Diagnostic Test, covering the supply chain analysis, impact assessment to the NGS-Based Monitoring and Diagnostic Test market size growth rate in several scenarios, and the measures to be undertaken by NGS-Based Monitoring and Diagnostic Test companies in response to the COVID-19 epidemic.
Segmentation by product type:
- Commercial Assays/Tests
- Laboratory Developed Tests
- Direct To Consumer Test
- Pre-Commercial Tests
Segmentation by Application:
- Out-Patient Clinics/General Practitioners
- Diagnostic Centers
- Hospitals
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/players in the market. The key players covered in this report:
- Agilent Technologies, Inc.
- Laboratory Corporation of America Holdings
- Ancestry.com LLC
- Beijing Genomics Institute (BGI)
- Cancer Genetics, Inc.
- ArcherDX, Inc.
- GenePath Dx
- CENTOGENE AG
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd
- HTG Molecular Diagnostics, Inc.
- Vela Diagnostics Pte. Ltd.
- Myriad Genetics, Inc.
- Siemens Healthineers, Inc.
- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
- To study and analyze the global NGS-Based Monitoring and Diagnostic Test market size by key regions/countries, type and application.
- To understand the structure of NGS-Based Monitoring and Diagnostic Test market by identifying its various subsegments.
- Focuses on the key global NGS-Based Monitoring and Diagnostic Test players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the NGS-Based Monitoring and Diagnostic Test with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the size of NGS-Based Monitoring and Diagnostic Test submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.